| 86R9520 JSC-D  
---|---  
|  By: Dean | H.B. No. 2087  
---  
|  A BILL TO BE ENTITLED  
|  AN ACT  
| relating to Schedule II controlled substance prescriptions under  
| the Texas Controlled Substances Act.  
|  BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:  
|  SECTION 1. Section 481.003(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) The director may adopt rules to administer and enforce  
| this chapter, other than Sections 481.073, 481.074, 481.075,  
| _481.0755,_ 481.076, 481.0761, 481.0762, 481.0763, 481.0764,  
| 481.0765, and 481.0766. The board may adopt rules to administer  
| Sections 481.073, 481.074, 481.075, _481.0755,_ 481.076, 481.0761,  
| 481.0762, 481.0763, 481.0764, 481.0765, and 481.0766.  
|  SECTION 2. Subchapter C, Chapter 481, Health and Safety  
| Code, is amended by adding Section 481.0755 to read as follows:  
|  _Sec._ ___481.0755._ _____WRITTEN, ORAL, AND TELEPHONICALLY_  
| _COMMUNICATED PRESCRIPTIONS FOR SCHEDULE II CONTROLLED SUBSTANCES._  
| _(a) Notwithstanding any other provision of this subchapter, a_  
| _person prescribing or dispensing a Schedule II controlled substance_  
| _must use the electronic prescription record and may not use a_  
| _written, oral, or telephonically communicated prescription._  
|  _(b)_ _____A prescriber may issue a written, oral, or_  
| _telephonically communicated prescription for a Schedule II_  
| _controlled substance as authorized under this subchapter only if_  
| _the prescription is issued in an emergency, as defined by board_  
| _rule._  
|  _(c)_ _____A written, oral, or telephonically communicated_  
| _prescription must comply with the applicable requirements_  
| _prescribed by Sections 481.074 and 481.075._  
|  SECTION 3. Section 481.128(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) A registrant or dispenser commits an offense if the  
| registrant or dispenser knowingly:  
|  (1) distributes, delivers, administers, or dispenses  
| a controlled substance in violation of Sections _481.070-481.0755_  
| [ ~~481.070-481.075~~ ];  
|  (2) manufactures a controlled substance not  
| authorized by the person's Federal Drug Enforcement Administration  
| registration or distributes or dispenses a controlled substance not  
| authorized by the person's registration to another registrant or  
| other person;  
|  (3) refuses or fails to make, keep, or furnish a  
| record, report, notification, order form, statement, invoice, or  
| information required by this chapter;  
|  (4) prints, manufactures, possesses, or produces an  
| official prescription form without the approval of the board;  
|  (5) delivers or possesses a counterfeit official  
| prescription form;  
|  (6) refuses an entry into a premise for an inspection  
| authorized by this chapter;  
|  (7) refuses or fails to return an official  
| prescription form as required by Section 481.075(k);  
|  (8) refuses or fails to make, keep, or furnish a  
| record, report, notification, order form, statement, invoice, or  
| information required by a rule adopted by the director or the board;  
| or  
|  (9) refuses or fails to maintain security required by  
| this chapter or a rule adopted under this chapter.  
|  SECTION 4. Section 481.129(a), Health and Safety Code, is  
| amended to read as follows:  
|  (a) A person commits an offense if the person knowingly:  
|  (1) distributes as a registrant or dispenser a  
| controlled substance listed in Schedule I or II, unless the person  
| distributes the controlled substance as authorized under the  
| federal Controlled Substances Act (21 U.S.C. Section 801 et seq.);  
|  (2) uses in the course of manufacturing, prescribing,  
| or distributing a controlled substance a Federal Drug Enforcement  
| Administration registration number that is fictitious, revoked,  
| suspended, or issued to another person;  
|  (3) issues a prescription bearing a forged or  
| fictitious signature;  
|  (4) uses a prescription issued to another person to  
| prescribe a Schedule II controlled substance;  
|  (5) possesses, obtains, or attempts to possess or  
| obtain a controlled substance or an increased quantity of a  
| controlled substance:  
|  (A) by misrepresentation, fraud, forgery,  
| deception, or subterfuge;  
|  (B) through use of a fraudulent prescription  
| form; [ ~~or~~ ]  
|  (C) through use of a fraudulent oral or  
| telephonically communicated prescription; or  
|  _(D)_ _____through the use of a fraudulent electronic_  
| _prescription; or_  
|  (6) furnishes false or fraudulent material  
| information in or omits material information from an application,  
| report, record, or other document required to be kept or filed under  
| this chapter.  
|  SECTION 5. Section 554.051(a-1), Occupations Code, is  
| amended to read as follows:  
|  (a-1) The board may adopt rules to administer Sections  
| 481.073, 481.074, 481.075, _481.0755,_ 481.076, 481.0761, 481.0762,  
| 481.0763, 481.0764, 481.0765, and 481.0766, Health and Safety Code.  
|  SECTION 6. Section 565.003, Occupations Code, is amended to  
| read as follows:  
|  Sec. 565.003. ADDITIONAL GROUNDS FOR DISCIPLINE REGARDING  
| APPLICANT FOR OR HOLDER OF NONRESIDENT PHARMACY LICENSE. Unless  
| compliance would violate the pharmacy or drug statutes or rules in  
| the state in which the pharmacy is located _,_ the board may discipline  
| an applicant for or the holder of a nonresident pharmacy license if  
| the board finds that the applicant or license holder has failed to  
| comply with:  
|  (1) Section _481.073,_ 481.074 _,_ [ ~~or~~ ] 481.075, _481.0755,_  
| _481.076, 481.0761, 481.0762, 481.0763, 481.0764, 481.0765, or_  
| _481.0766,_ Health and Safety Code;  
|  (2) Texas substitution requirements regarding:  
|  (A) the practitioner's directions concerning  
| generic substitution;  
|  (B) the patient's right to refuse generic  
| substitution; or  
|  (C) notification to the patient of the patient's  
| right to refuse substitution;  
|  (3) any board rule relating to providing drug  
| information to the patient or the patient's agent in written form or  
| by telephone; or  
|  (4) any board rule adopted under Section 554.051(a)  
| and determined by the board to be applicable under Section  
| 554.051(b).  
|  SECTION 7. The change in law made by this Act applies only  
| to a prescription issued on or after the effective date of this Act.  
| A prescription issued before the effective date of this Act is  
| governed by the law in effect immediately before the effective date  
| of this Act, and the former law is continued in effect for that  
| purpose.  
|  SECTION 8. This Act takes effect September 1, 2019.

